Heron Therapeutics Stock (NASDAQ: HRTX) stock price, news, charts, stock research, profile.
Open | $2.980 |
Close | $2.770 |
Volume / Avg. | 1.992M / 2.379M |
Day Range | 2.725 - 3.050 |
52 Wk Range | 0.500 - 3.220 |
Market Cap | $417.309M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 21.87% |
Days to Cover | 18.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Heron Therapeutics (NASDAQ: HRTX) through any online brokerage.
Other companies in Heron Therapeutics’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Replimune Group (NASDAQ:REPL), PepGen (NASDAQ:PEPG), Fate Therapeutics (NASDAQ:FATE) and Anika Therapeutics (NASDAQ:ANIK).
The latest price target for Heron Therapeutics (NASDAQ: HRTX) was reported by Needham on Wednesday, May 8, 2024. The analyst firm set a price target for 5.00 expecting HRTX to rise to within 12 months (a possible 80.51% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $2.77 last updated May 10, 2024 at 5:27 PM EDT.
There are no upcoming dividends for Heron Therapeutics.
Heron Therapeutics’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Heron Therapeutics.
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.